ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.26
0.08%
US Tech 100
19,553.60
-0.13%
S&P 500
5,759.98
0.25%
US Dollar vs CAD
1.34795
0.01%
Bitcoin
66,372.00
1.82%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cingulate Inc (CINGW)

  7. Cingulate Inc (CINGW) News

CINGW

Cingulate (CINGW)

Cingulate Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CINGW
DateTimeSourceHeadlineSymbolCompany
09/27/20245:24AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CINGWCingulate Inc
09/12/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
09/12/20247:30AMGlobeNewswire Inc.Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301NASDAQ:CINGWCingulate Inc
09/10/20245:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
08/27/20243:30PMGlobeNewswire Inc.Cingulate to Participate in Benzinga All Live Access EventNASDAQ:CINGWCingulate Inc
08/23/20243:45PMGlobeNewswire Inc.Cingulate Announces Adjournment of Special MeetingNASDAQ:CINGWCingulate Inc
08/15/20246:45AMGlobeNewswire Inc.Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHDNASDAQ:CINGWCingulate Inc
08/13/20246:45AMGlobeNewswire Inc.Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones AchievedNASDAQ:CINGWCingulate Inc
06/28/20248:15AMGlobeNewswire Inc.Cingulate Announces Exercise of Warrants for $1.86 Million Gross ProceedsNASDAQ:CINGWCingulate Inc
06/25/20243:30PMGlobeNewswire Inc.Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access EventNASDAQ:CINGWCingulate Inc
06/25/20248:20AMGlobeNewswire Inc.Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing ClearanceNASDAQ:CINGWCingulate Inc
06/18/20244:00PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CINGWCingulate Inc
06/18/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
06/13/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
06/13/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
06/13/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
06/13/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
06/13/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
06/13/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
06/13/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
06/12/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
06/07/20245:00PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CINGWCingulate Inc
05/28/20244:54PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CINGWCingulate Inc
05/28/20248:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
05/23/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CINGWCingulate Inc
05/23/20244:01PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CINGWCingulate Inc
05/21/20248:00AMGlobeNewswire Inc.FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHDNASDAQ:CINGWCingulate Inc
05/17/20244:01PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CINGWCingulate Inc
05/13/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
05/08/20246:15AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CINGWCingulate Inc
 Showing the most relevant articles for your search:NASDAQ:CINGW

Your Recent History

USOTC
QSEP
QS Energy (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
TGRP
TRON (PK)
USOTC
NBRI
North Bay Resources (PK)
USOTC
IDVV
International Endeavors (PK)
USOTC
AXXA
Exxe (PK)
USOTC
VHAI
Vocodia (PK)
USOTC
MVNT
Movement Industries (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
GDVM
Global Developments (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
HIRU
Hiru (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved